We are live on ! Find out more
SXTPW icon

60 Degrees Pharmaceuticals Warrant
SXTPW

8 hedge funds and large institutions have $24.4K invested in 60 Degrees Pharmaceuticals Warrant in 2026 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 2 increasing their positions, 5 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 8 → 8 (0)

21% less capital invested

Capital invested by funds: $30.9K → $24.4K (-$6.5K)

60% less repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 5

Holders
8
Holders Change
–
Holders Change %
0%
% of All Funds
0.1%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
2
Reduced
5
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$71
2
CS
Clear Street
New York
+$12

Top Sellers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
-$204
2
TSS
Two Sigma Securities
New York
-$134
3
Walleye Capital
Walleye Capital
New York
-$51
4
UBS Group
UBS Group
Switzerland
-$6

SXTPW Hedge Fund Activity: Q1 2026 in Review

8 of the 8,191 institutional investors tracked by Wall St. Rank reported a position in 60 Degrees Pharmaceuticals Warrant (SXTPW) for Q1 2026, worth a combined $24.4K — down 21% from $30.9K a quarter earlier.

Fund positioning in SXTPW was balanced in Q1 2026: 0 funds opened new positions, 0 closed out, 2 added to existing stakes and 5 trimmed.

The largest buyer was Susquehanna International Group, adding an estimated $71. The largest seller was Citadel Advisors, cutting an estimated $204.

  • 8 institutional investors held 60 Degrees Pharmaceuticals Warrant (SXTPW) as of Q1 2026, unchanged from Q4 2025.
  • Funds reported $24.4K of 60 Degrees Pharmaceuticals Warrant stock for Q1 2026, down 21% quarter-over-quarter.
  • 0 funds opened new 60 Degrees Pharmaceuticals Warrant positions in Q1 2026 and 0 closed out.
  • The largest 60 Degrees Pharmaceuticals Warrant buyer in Q1 2026 was Susquehanna International Group, an estimated $71 added.
  • The largest 60 Degrees Pharmaceuticals Warrant seller in Q1 2026 was Citadel Advisors, an estimated $204 sold.

Based on aggregated 13F filings for Q1 2026.